Learn more about Laxxon Medical's groundbreaking 3D printed oral GLP-1 asset, offering an alternative to injections in obesity treatments.

Laxxon Medical announced its participation in the 2024 BIO International Convention, to showcase its LXM.2 asset to potential partners.

Learn all about GLP-1 medications for diabetes and obesity, including benefits, side effects, and how they work.

Explore the future of drug delivery, Laxxon Medical's innovative 3D technology, and how controlled-release drugs are reshaping healthcare.

Join Dr.Catherine Gatza, our VP of Regulatory Affairs, at the World Orphan Drug Congress USA 2024, in Boston, Massachusetts.

Laxxon's extended-release Levodopa is revolutionizing Parkinson's treatment, increasing patient quality of life with improved medication.

3D screen printing could revolutionize the fight against counterfeit medication, innovating anti-counterfeiting measures for patient safety.

Learn how Laxxon Medical's 3D screen printing and QR codes combat counterfeit medicine. Discover the impact on safety and global healthcare.

Laxxon Medical, a pioneering pharma-technology company, is set to participate in the 23rd Annual Needham Virtual Health Conference.

Discover how Laxxon Medical's patent for the sequential release of multiple drugs in pharmaceutical dosage forms revolutionizes healthcare.

Delve into the complexities of obesity, from its global impact to the physical, mental, and social effects, and various treatment options.

Discover how 3D screen printing revolutionizes the fight against counterfeit drugs with unique covert features in oral dosage forms.

Discover the world of diabetes, from causes to treatments. Explore the latest research and advancements in managing this complex disease.

Explore the delicate balance between pharmaceutical patent extensions and patient access in healthcare and it's role in driving innovation.

Discover how technology like Generative AI, IoMT, and 3D Printing is accelerating pharma research, enhancing speed, efficiency and accuracy.

Learn about the FDA 505b2 Pathway, a streamlined NDA process benefiting pharmaceutical companies with reduced costs and faster drug approval

Discover how pulsatile release drug delivery systems can revolutionize medication efficacy, and the treatment of various conditions.

3D printing and smart technologies are transforming the pharma industry. From personalized medicine to revolutionizing drug delivery.

Discover how advancing medication with the right DDS can revolutionize drug delivery. Learn about immediate and delayed release techniques.

Discover the groundbreaking pharmaceutical advancements of Laxxon Medical at the 26th Annual Needham Growth Conference.